A 6 year old male Miniature Schnauzer was presented to the Internal Medicine service with a history of reduced appetite, intermittent vomiting and abdominal pain. On clinical examination, the body weight was 8.2 kg with a condition score of 8/9. The heart rate was 96 bpm, and the respiratory rate was 32 breaths per minute with no adventitious lung sounds. The rectal temperature was 38.9ᵒC.
RBC (x 10
12 /l) 6.9 5.5-8.5 PCV (%) 49 
1) What is the likely diagnosis for this dog?
The ultrasound image demonstrates the presence of organised, immobile gallbladder contents with a striated appearance radiating between the wall and centre consistent with a gallbladder mucocoele. This diagnosis is supported by the clinical signs and liver enzyme elevations, with alkaline phosphatase being the predominantly increased parameter. About 40% of cases are also icteric, which was not the case with this patient. If free fluid is present or the surrounding fat is hyperechoic on ultrasound examination, this suggests possible gallbladder rupture.
2) What other investigation would you like to perform for dogs with this condition?
Gallbladder mucocoeles can occur secondary to dyslipidaemias and endocrine disease, so it is prudent to check serum cholesterol and triglyceride levels and also test for hyperadrenocorticism and hypothyroidism. Other predisposing factors include breed (Shetland sheepdog, Miniature Schnauzer and Cocker spaniel), steroid administration and gallbladder dysmotility.
3) What are the treatment options?
Treatment options are either medical or surgical. Surgical treatment would normally be removal of the gallbladder (cholecystectomy). Since concurrent bacterial infections are common, antibiotic therapy is also indicated using an agent that gives anaerobic cover. The main concern is in the peri-operative period, with mortality recorded between 22-40%. Those that survive the peri-operative period have an excellent prognosis.
Medical therapy has been documented to be successful in stable patients who do not have evidence of gallbladder rupture and bile peritonitis. Treatment of an underlying endocrinopathy is mandatory. Dyslipidaemias are managed with treatment of the underlying endocrinopathy if present and low fat diet. The other mainstays of treatment include ursodeoxycholic acid, s-adenosylmethonine (SAMe) and a prolonged antibiotic course (typically 4-8 weeks), with periodic monitoring of blood parameters and gallbladder ultrasound examinations.
